14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today BIOS ranks #13072 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

BioScrip Stock Forecast NASDAQ:BIOS

$22.44 (-2.86%)

Volume: 1M

Closed: Jan 25, 2022

Hollow Logo Score: -3.507

BioScrip Stock Forecast

$22.44 (-2.86%)

Volume: 1M

Closed: Jan 25, 2022

Score Hollow Logo -3.507

BioScrip Company Profile

1600 Broadway

Denver CO 80202





BioScrip, Inc. provides home infusion services in the United States. The company engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. It is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. BioScrip, Inc. offers its services at patient’s homes, outpatient clinics, nursing facilities, physician’s offices, and ambulatory infusion centers. The company markets and sells its products and services through sales and marketing representatives, payor relationships, and other government programs. BioScrip, Inc. was founded in 1993 and is based in Denver, Colorado.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE